Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b,Condition 2a,Condition 2b,Condition 2c,Condition 3a,Condition 3b,Condition 3c
3196,"Silecchia G, etal., Cancer Immunol Immunother. 1999 Jul;48(4):172-8. doi: 10.1007/s002620050562.",CD4-positive T cell quantity,,RS:0001792,BDIX/OrlCrl,male,77 days to 63 days,16,,CMO:0000596,blood CD4 cell count,,baseline saline control group,,2.058,x 1000 cells/ul,0.1668,0.667,MMO:0000310,fluorescence-activated cell sorting method,,0.0,baseline,,0,days,0.9% sodium chloride solution (2 ml) ,111106,0.9% sodium chloride solution (2 ml) ,,,,,,,
3196,"Silecchia G, etal., Cancer Immunol Immunother. 1999 Jul;48(4):172-8. doi: 10.1007/s002620050562.",CD4-positive T cell quantity,,RS:0001792,BDIX/OrlCrl,male,91 days to 77 days,16,,CMO:0000596,blood CD4 cell count,,saline control group,,2.758,x 1000 cells/ul,0.2398,0.959,MMO:0000310,fluorescence-activated cell sorting method,,0.0,sham,,14,days,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours) and splenectomy then 0.9% sodium chloride solution (2 ml) (for 7 days),111107,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours),splenectomy,0.9% sodium chloride solution (2 ml) (for 7 days),,,,,
3196,"Silecchia G, etal., Cancer Immunol Immunother. 1999 Jul;48(4):172-8. doi: 10.1007/s002620050562.",CD4-positive T cell quantity,,RS:0001792,BDIX/OrlCrl,male,105 days to 91 days,16,,CMO:0000596,blood CD4 cell count,,saline control group,,1.81,x 1000 cells/ul,0.0805,0.322,MMO:0000310,fluorescence-activated cell sorting method,,0.0,saline control,,28,days,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours) and splenectomy then 0.9% sodium chloride solution (2 ml) (for 7 days),111108,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours),splenectomy,0.9% sodium chloride solution (2 ml) (for 7 days),,,,,
3196,"Silecchia G, etal., Cancer Immunol Immunother. 1999 Jul;48(4):172-8. doi: 10.1007/s002620050562.",CD4-positive T cell quantity,,RS:0001792,BDIX/OrlCrl,male,125 days to 111 days,16,,CMO:0000596,blood CD4 cell count,,saline control group,,1.568,x 1000 cells/ul,0.06,0.24,MMO:0000310,fluorescence-activated cell sorting method,,0.0,saline control,,48,days,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours) and splenectomy then 0.9% sodium chloride solution (2 ml) (for 7 days) then 0.9% sodium chloride solution (2 ml) (for 7 days),111109,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours),splenectomy,0.9% sodium chloride solution (2 ml) (for 7 days),,,0.9% sodium chloride solution (2 ml) (for 7 days),,
3196,"Silecchia G, etal., Cancer Immunol Immunother. 1999 Jul;48(4):172-8. doi: 10.1007/s002620050562.",CD4-positive T cell quantity,,RS:0001792,BDIX/OrlCrl,male,105 days to 91 days,18,,CMO:0000596,blood CD4 cell count,,fluorouracil 5-FU,,0.956,x 1000 cells/ul,0.0589,0.25,MMO:0000310,fluorescence-activated cell sorting method,,0.0,one treatment,,28,days,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours) and splenectomy then 5-fluorouracil (100 mg/kg) (for 7 days),111110,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours),splenectomy,5-fluorouracil (100 mg/kg) (for 7 days),,,,,
3196,"Silecchia G, etal., Cancer Immunol Immunother. 1999 Jul;48(4):172-8. doi: 10.1007/s002620050562.",CD4-positive T cell quantity,,RS:0001792,BDIX/OrlCrl,male,125 days to 111 days,18,,CMO:0000596,blood CD4 cell count,,fluorouracil 5-FU,,0.299,x 1000 cells/ul,0.0837,0.355,MMO:0000310,fluorescence-activated cell sorting method,,0.0,two treatments,,48,days,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours) and splenectomy then 5-fluorouracil (100 mg/kg) (for 7 days) then 5-fluorouracil (100 mg/kg) (for 7 days),111111,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours),splenectomy,5-fluorouracil (100 mg/kg) (for 7 days),,,5-fluorouracil (100 mg/kg) (for 7 days),,
3196,"Silecchia G, etal., Cancer Immunol Immunother. 1999 Jul;48(4):172-8. doi: 10.1007/s002620050562.",CD4-positive T cell quantity,,RS:0001792,BDIX/OrlCrl,male,105 days to 91 days,18,,CMO:0000596,blood CD4 cell count,,fluorouracil 5-FU + IL2,,1.878,x 1000 cells/ul,0.0679,0.288,MMO:0000310,fluorescence-activated cell sorting method,,0.0,one treatment,,28,days,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours) and splenectomy then 5-fluorouracil (100 mg/kg) (for 7 days) and interleukin-2 (75000 U/d) (for 4 days),111112,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours),splenectomy,5-fluorouracil (100 mg/kg) (for 7 days),interleukin-2 (75000 U/d) (for 4 days),,,,
3196,"Silecchia G, etal., Cancer Immunol Immunother. 1999 Jul;48(4):172-8. doi: 10.1007/s002620050562.",CD4-positive T cell quantity,,RS:0001792,BDIX/OrlCrl,male,125 days to 111 days,18,,CMO:0000596,blood CD4 cell count,,fluorouracil 5-FU +IL-2,,2.222,x 1000 cells/ul,0.0606,0.257,MMO:0000310,fluorescence-activated cell sorting method,,0.0,two treatments,,48,days,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours) and splenectomy then 5-fluorouracil (100 mg/kg) (for 7 days) and interleukin-2 (75000 U/d) (for 4 days) then 5-fluorouracil (100 mg/kg) (for 7 days) and interleukin-2 (75000 U/d) (for 4 days),111113,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours),splenectomy,5-fluorouracil (100 mg/kg) (for 7 days),interleukin-2 (75000 U/d) (for 4 days),,5-fluorouracil (100 mg/kg) (for 7 days),interleukin-2 (75000 U/d) (for 4 days),
3196,"Silecchia G, etal., Cancer Immunol Immunother. 1999 Jul;48(4):172-8. doi: 10.1007/s002620050562.",CD4-positive T cell quantity,,RS:0001792,BDIX/OrlCrl,male,105 days to 91 days,21,,CMO:0000596,blood CD4 cell count,,fluorouracil 5-FU + IL2 +Ta1,,3.39,x 1000 cells/ul,0.1569,0.719,MMO:0000310,fluorescence-activated cell sorting method,,0.0,one treatment,,28,days,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours) and splenectomy then 5-fluorouracil (100 mg/kg) (for 7 days) and interleukin-2 (75000 U/d) (for 4 days) and Thymosin alpha-1 (200 ug/kg) (for 4 days),111114,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours),splenectomy,5-fluorouracil (100 mg/kg) (for 7 days),interleukin-2 (75000 U/d) (for 4 days),Thymosin alpha-1 (200 ug/kg) (for 4 days),,,
3196,"Silecchia G, etal., Cancer Immunol Immunother. 1999 Jul;48(4):172-8. doi: 10.1007/s002620050562.",CD4-positive T cell quantity,,RS:0001792,BDIX/OrlCrl,male,125 days to 111 days,21,,CMO:0000596,blood CD4 cell count,,fluorouracil 5-FU +IL-2+ Ta1,,4.502,x 1000 cells/ul,0.23,1.054,MMO:0000310,fluorescence-activated cell sorting method,,0.0,two treatments,,48,days,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours) and splenectomy then 5-fluorouracil (100 mg/kg) (for 7 days) and interleukin-2 (75000 U/d) (for 4 days) and Thymosin alpha-1 (200 ug/kg) (between 44 and 4 days) then 5-fluorouracil (100 mg/kg) (for 7 days) and interleukin-2 (75000 U/d) (for 4 days) and Thymosin alpha-1 (200 ug/kg) (for 4 days),111115,DHD/K12/TRb cells (9 X 10E6) (for 0.1 hours),splenectomy,5-fluorouracil (100 mg/kg) (for 7 days),interleukin-2 (75000 U/d) (for 4 days),Thymosin alpha-1 (200 ug/kg) (between 44 and 4 days),5-fluorouracil (100 mg/kg) (for 7 days),interleukin-2 (75000 U/d) (for 4 days),Thymosin alpha-1 (200 ug/kg) (for 4 days)